CDKN2A and cancer: We evaluated the effects of PSM.7-LP on the activity of ERE73 (1 + 2)-ARF (−13), ERE73 (3 + 4)-ARF (−13), and E2WT-ARF (−13), and the analogous mutant constructs, in human normal fibroblasts (HFFs) and the cancer cell lines.